nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—melanoma	0.474	1	CbGaD
Clenbuterol—CYP1A1—Dacarbazine—melanoma	0.111	0.361	CbGbCtD
Clenbuterol—CYP1A2—Carmustine—melanoma	0.0821	0.266	CbGbCtD
Clenbuterol—CYP1A2—Vemurafenib—melanoma	0.0649	0.211	CbGbCtD
Clenbuterol—CYP1A2—Dacarbazine—melanoma	0.0497	0.161	CbGbCtD
Clenbuterol—CYP1A2—Metabolism—GPAM—melanoma	9.35e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—melanoma	9.35e-06	4.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.32e-06	4.27e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MAPK1—melanoma	9.32e-06	4.27e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—melanoma	9.31e-06	4.27e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PIK3CA—melanoma	9.23e-06	4.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	9.2e-06	4.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SOCS1—melanoma	9.11e-06	4.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	9.09e-06	4.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—S100B—melanoma	9.09e-06	4.16e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAP2K1—melanoma	9.05e-06	4.15e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	9.03e-06	4.14e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CD—melanoma	8.99e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—melanoma	8.95e-06	4.1e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—melanoma	8.93e-06	4.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNA11—melanoma	8.93e-06	4.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SOCS1—melanoma	8.91e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—melanoma	8.9e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	8.89e-06	4.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—S100B—melanoma	8.89e-06	4.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	8.83e-06	4.05e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—melanoma	8.8e-06	4.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—FASN—melanoma	8.74e-06	4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB4—melanoma	8.69e-06	3.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	8.67e-06	3.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN2B—melanoma	8.62e-06	3.95e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF2—melanoma	8.6e-06	3.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC5A5—melanoma	8.59e-06	3.94e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—melanoma	8.54e-06	3.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB4—melanoma	8.5e-06	3.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	8.48e-06	3.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN2B—melanoma	8.43e-06	3.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD86—melanoma	8.33e-06	3.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	8.33e-06	3.82e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNAQ—melanoma	8.3e-06	3.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD44—melanoma	8.3e-06	3.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—melanoma	8.27e-06	3.79e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—melanoma	8.26e-06	3.78e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—melanoma	8.17e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD86—melanoma	8.15e-06	3.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	8.15e-06	3.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.13e-06	3.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—melanoma	8.09e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—melanoma	8.08e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CSF2—melanoma	8.08e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF1—melanoma	8.08e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.05e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—melanoma	8.05e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—melanoma	7.96e-06	3.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP1B1—melanoma	7.96e-06	3.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G6—melanoma	7.95e-06	3.64e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2—melanoma	7.94e-06	3.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—E2F1—melanoma	7.91e-06	3.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CSF2—melanoma	7.9e-06	3.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF1—melanoma	7.9e-06	3.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	7.87e-06	3.61e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CB—melanoma	7.83e-06	3.59e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFRA—melanoma	7.83e-06	3.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—melanoma	7.79e-06	3.57e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ITGB3—melanoma	7.75e-06	3.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCA—melanoma	7.75e-06	3.55e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—E2F1—melanoma	7.73e-06	3.54e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	7.7e-06	3.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFRA—melanoma	7.65e-06	3.51e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—melanoma	7.6e-06	3.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ITGB3—melanoma	7.58e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCA—melanoma	7.58e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAP2K2—melanoma	7.57e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—melanoma	7.56e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—melanoma	7.54e-06	3.46e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—melanoma	7.53e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—melanoma	7.48e-06	3.43e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—melanoma	7.43e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAP2K2—melanoma	7.41e-06	3.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—melanoma	7.4e-06	3.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1B—melanoma	7.35e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—melanoma	7.27e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—melanoma	7.23e-06	3.31e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—melanoma	7.2e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—melanoma	7.2e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—melanoma	7.19e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAC1—melanoma	7.18e-06	3.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—melanoma	7.16e-06	3.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—VCAN—melanoma	7.14e-06	3.27e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—melanoma	7.07e-06	3.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—melanoma	7.04e-06	3.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAC1—melanoma	7.03e-06	3.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.02e-06	3.22e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—melanoma	7.01e-06	3.21e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CTNNB1—melanoma	6.94e-06	3.18e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIF1A—melanoma	6.89e-06	3.16e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—melanoma	6.81e-06	3.12e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—melanoma	6.78e-06	3.11e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—melanoma	6.77e-06	3.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.76e-06	3.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIF1A—melanoma	6.74e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKB1—melanoma	6.74e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—melanoma	6.6e-06	3.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—melanoma	6.59e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCB1—melanoma	6.55e-06	3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.53e-06	2.99e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—melanoma	6.44e-06	2.95e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FN1—melanoma	6.34e-06	2.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH1—melanoma	6.2e-06	2.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FN1—melanoma	6.2e-06	2.84e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—melanoma	6.11e-06	2.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD80—melanoma	6.08e-06	2.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH1—melanoma	6.07e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—melanoma	6.07e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KIT—melanoma	6.07e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APC—melanoma	6.07e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NRAS—melanoma	6.07e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—melanoma	6.05e-06	2.77e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRAS—melanoma	6.04e-06	2.77e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PRKCA—melanoma	6.03e-06	2.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP17A1—melanoma	6.03e-06	2.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGF—melanoma	6e-06	2.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ERCC2—melanoma	5.98e-06	2.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD80—melanoma	5.95e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.94e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APC—melanoma	5.94e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—melanoma	5.94e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KIT—melanoma	5.94e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NRAS—melanoma	5.94e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.87e-06	2.69e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGF—melanoma	5.87e-06	2.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK3—melanoma	5.81e-06	2.66e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK3—melanoma	5.78e-06	2.65e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BRAF—melanoma	5.7e-06	2.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNA11—melanoma	5.69e-06	2.61e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK3—melanoma	5.68e-06	2.6e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—melanoma	5.63e-06	2.58e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BRAF—melanoma	5.58e-06	2.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FASN—melanoma	5.57e-06	2.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—melanoma	5.56e-06	2.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK1—melanoma	5.53e-06	2.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—melanoma	5.53e-06	2.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK1—melanoma	5.5e-06	2.52e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—melanoma	5.5e-06	2.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC5A5—melanoma	5.48e-06	2.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—melanoma	5.43e-06	2.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK1—melanoma	5.41e-06	2.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—melanoma	5.41e-06	2.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAP2K1—melanoma	5.37e-06	2.46e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CD—melanoma	5.33e-06	2.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNAQ—melanoma	5.29e-06	2.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD44—melanoma	5.29e-06	2.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	5.28e-06	2.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAP2K1—melanoma	5.25e-06	2.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—melanoma	5.22e-06	2.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CD—melanoma	5.22e-06	2.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—melanoma	5.2e-06	2.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.18e-06	2.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	5.17e-06	2.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.13e-06	2.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—melanoma	5.11e-06	2.34e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF2—melanoma	5.11e-06	2.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1B1—melanoma	5.07e-06	2.32e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF2—melanoma	5e-06	2.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.95e-06	2.27e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	4.8e-06	2.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—melanoma	4.78e-06	2.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—melanoma	4.78e-06	2.19e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—melanoma	4.72e-06	2.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2—melanoma	4.71e-06	2.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	4.69e-06	2.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—melanoma	4.67e-06	2.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CB—melanoma	4.65e-06	2.13e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—melanoma	4.62e-06	2.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2—melanoma	4.61e-06	2.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—melanoma	4.56e-06	2.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CB—melanoma	4.55e-06	2.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.48e-06	2.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—melanoma	4.47e-06	2.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—melanoma	4.44e-06	2.03e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—melanoma	4.42e-06	2.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—melanoma	4.37e-06	2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1B—melanoma	4.36e-06	2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—melanoma	4.34e-06	1.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—melanoma	4.32e-06	1.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—melanoma	4.28e-06	1.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—melanoma	4.27e-06	1.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1B—melanoma	4.27e-06	1.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—melanoma	4.25e-06	1.95e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—melanoma	4.23e-06	1.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—melanoma	4.22e-06	1.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—melanoma	4.18e-06	1.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCB1—melanoma	4.18e-06	1.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—melanoma	4.18e-06	1.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—melanoma	4.16e-06	1.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—melanoma	4.16e-06	1.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CD—melanoma	4.15e-06	1.9e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CTNNB1—melanoma	4.12e-06	1.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—melanoma	4.1e-06	1.88e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—melanoma	4.07e-06	1.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—melanoma	4.04e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CTNNB1—melanoma	4.03e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—melanoma	4.03e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—melanoma	4.02e-06	1.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKB1—melanoma	4e-06	1.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—melanoma	3.95e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—melanoma	3.94e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—melanoma	3.93e-06	1.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—melanoma	3.92e-06	1.8e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKB1—melanoma	3.91e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—melanoma	3.9e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PRKCA—melanoma	3.84e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—melanoma	3.83e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ERCC2—melanoma	3.81e-06	1.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—melanoma	3.63e-06	1.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CB—melanoma	3.62e-06	1.66e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—melanoma	3.59e-06	1.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—melanoma	3.59e-06	1.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRAS—melanoma	3.58e-06	1.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—melanoma	3.55e-06	1.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—melanoma	3.51e-06	1.61e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRAS—melanoma	3.51e-06	1.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK3—melanoma	3.43e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK3—melanoma	3.36e-06	1.54e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—melanoma	3.34e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK1—melanoma	3.27e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—melanoma	3.27e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—melanoma	3.27e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK1—melanoma	3.2e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—melanoma	3.19e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.16e-06	1.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—melanoma	3.13e-06	1.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—melanoma	3.08e-06	1.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—melanoma	3.02e-06	1.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—melanoma	3.01e-06	1.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—melanoma	2.91e-06	1.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.83e-06	1.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—melanoma	2.77e-06	1.27e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—melanoma	2.74e-06	1.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—melanoma	2.68e-06	1.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CD—melanoma	2.65e-06	1.21e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—melanoma	2.62e-06	1.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—melanoma	2.61e-06	1.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—melanoma	2.57e-06	1.18e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—melanoma	2.51e-06	1.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—melanoma	2.46e-06	1.13e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—melanoma	2.32e-06	1.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CB—melanoma	2.31e-06	1.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—melanoma	2.29e-06	1.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—melanoma	2.26e-06	1.04e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—melanoma	2.21e-06	1.01e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—melanoma	1.99e-06	9.14e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—melanoma	1.8e-06	8.26e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—melanoma	1.41e-06	6.45e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—melanoma	1.15e-06	5.27e-06	CbGpPWpGaD
